SCHEMBL30937672

SCHEMBL30937672

N#Cc1ccc2c(c1F)CN(CC(=O)O)C(=O)N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.41
▸ MMP13 P45452 1/20 0.41
▸ STAT3 P40763 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.33
▸ AR P10275 4/20 0.32
▸ CYP2D6 P10635 2/20 0.31
▸ CYP2C9 P11712 2/20 0.31
▸ CYP2C19 P33261 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ CRHBP P24387 1/20 0.30
▸ CRHR2 Q13324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937524 0.84 ACE (0.44) ACEMMP13CYP2D6CYP2C9CYP2C19
SCHEMBL30937741 0.83 ACE (0.36) ACEMMP13ARKMT2AKDM4E
SCHEMBL30937681 0.82 ACE (0.42) ACEMMP13CYP2D6CYP2C9CYP2C19
SCHEMBL31120591 0.76 ACE (0.45) ACEMMP13CYP2D6CYP2C9CYP2C19
SCHEMBL30937651 0.76 ACE (0.53) ACEMMP13CYP2D6CYP2C9CYP2C19
SCHEMBL30937570 0.75 ACE (0.36) ACEMMP13STAT3
SCHEMBL30937732 0.70 ACE (0.44) ACEMMP13FFAR4CYP2D6CYP2C9
SCHEMBL30937538 0.70 PER2 (0.45) CYP2D6CYP2C9CYP2C19KMT2AKDM4E
SCHEMBL30937727 0.69 ACE (0.35) ACEMMP13CYP2D6CYP2C9CYP2C19
SCHEMBL30937588 0.68 ACE (0.48) ACEMMP13CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback